Wells Fargo & Company Immix Biopharma, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 434 shares of IMMX stock, worth $1,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
434
Previous 391
11.0%
Holding current value
$1,024
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IMMX
# of Institutions
36Shares Held
5.09MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD1.56MShares$3.67 Million1.92% of portfolio
-
Bleichroeder LP New York, NY850KShares$2.01 Million0.81% of portfolio
-
Cable Car Capital LLC San Francisco, CA670KShares$1.58 Million2.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA456KShares$1.08 Million0.0% of portfolio
-
Lynwood Capital Management Inc.405KShares$955,80011.13% of portfolio
About Immix Biopharma, Inc.
- Ticker IMMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,910,100
- Market Cap $32.8M
- Description
- Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...